Nicholas Conrad Smith serves as Executive at Alto Neuroscience, Inc., where they oversee executive responsibilities. Since joining the company, Nicholas Conrad Smith has executed 4 insider transactions totaling $125.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 28, 2024 involved purchasing 4,550 shares valued at $75.3K.
Nicholas Conrad Smith currently holds 26,866 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas Conrad Smith has been a net buyer of ANRO stock. They have purchased $125.6K and sold $0 worth of shares.
Nicholas Conrad Smith's most recent insider trade was on Mar 28, 2024, when they purchased 4,550 shares at $16.56 per share.
Get notified when new Form 4 filings are submitted
| $15.80 |
| Discretionary |
| Mar 1, 2024 | ANRO | $0 | Award | 19,153 | $N/A | Discretionary |
| Feb 6, 2024 | ANRO | $25.0K | Purchase | 1,563 | $16.00 | Discretionary |